Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,460,982 papers from all fields of science
Search
Sign In
Create Free Account
Recombinant Prothymosin Alpha
Known as:
Prothymosin Alpha
A recombinant form of the endogenous polypeptide hormone that exerts immunomodulatory effects primarily on mononuclear cells. Prothymosin alpha…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
PTMA gene
PTMA protein, human
prothymosin alpha
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.
A. Teixeira
,
Benjamin C. Yen
,
+10 authors
A. Mosoian
Journal of Infectious Diseases
2015
Corpus ID: 205135744
Soluble factors from CD8(+) T cells and cervicovaginal mucosa of women are recognized as important in controlling human…
Expand
2014
2014
Immune responses induced by the TLR-4 agonist-based adjuvant prothymosin alpha.
P. Samara
,
K. Ioannou
,
+5 authors
O. Tsitsilonis
2014
Corpus ID: 81537712
11131 Background: The immunomodulator prothymosin α (proTα) stimulates immune subpopulations via generating an optimized cytokine…
Expand
2006
2006
The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients
Margarita Skopeliti
,
I. Voutsas
,
+8 authors
O. Tsitsilonis
Cancer Immunology and Immunotherapy
2006
Corpus ID: 33964607
Prothymosin α (proTα) is a 109 amino acid long polypeptide presenting distinct immunoenhancing activity in vitro and in vivo…
Expand
2005
2005
Promotion of murine antitumour activity by prothymosin α treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor α
M. Papanastasiou
,
C. Baxevanis
,
M. Papamichail
Cancer Immunology and Immunotherapy
2005
Corpus ID: 42186432
SummaryThe effect of prothymosin α (ProTα) on the survival of DBA/2 mice inoculated with syngeneic tumour cells was studied. DBA…
Expand
2002
2002
Study on the biological activity of recombinant human prothymosin α in vitro
Guo Bao-yu
2002
Corpus ID: 88143317
OBJECTIVE To study on the biological activity of human prothymosin α(ProTα) in vitro.METHODS The effects of ProTα on the E…
Expand
2001
2001
Retrovirus-mediated transfer of prothymosin gene inhibits tumor growth and prolongs survival in murine bladder cancer
A. Shiau
,
Pey‐Ru Lin
,
M-Y Chang
,
C. Wu
Gene Therapy
2001
Corpus ID: 9610618
To explore the potential use of prothymosin α(ProT), a putative thymic hormone, in gene therapy for bladder cancer, we generated…
Expand
1999
1999
Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin α
C. Baxevanis
,
G. Spanakos
,
+4 authors
M. Papamichail
Cancer Immunology and Immunotherapy
1999
Corpus ID: 24954868
Abstract Anti-CD3 monoclonal antibody (mAb) activates in vitro peripheral blood mononuclear cells (PBMC) to lyse a variety of…
Expand
1998
1998
Prothymosin α Stimulates Ca2+-dependent Phosphorylation of Elongation Factor 2 in Cellular Extracts*
F. Vega
,
A. Vidal
,
U. Hellman
,
C. Wernstedt
,
F. Domı́nguez
Journal of Biological Chemistry
1998
Corpus ID: 24679030
Prothymosin α (PTA) stimulates in a dose-dependent manner the phosphorylation of a 105-kDa protein (p105) in cell extracts from…
Expand
1997
1997
Recombinant human prothymosin alpha influences on immunity and behaviour
A. Khodyakova
,
G. A. Tsidulko
,
+6 authors
A. Bogdanov
1997
Corpus ID: 90748953
Highly Cited
1991
Highly Cited
1991
Expression of the rat prothymosin alpha gene during T-lymphocyte proliferation and liver regeneration.
X. Bustelo
,
A. Otero
,
J. Gómez-Márquez
,
M. Freire
Journal of Biological Chemistry
1991
Corpus ID: 28351335
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE